Outsourcing Pharma
OCTOBER 15, 2024
The big pharma company Sanofi has discontinued a phase 2 trial of U.S. partner Denali Therapeuticsâ oditrasertib for the treatment of multiple sclerosis after the drug failed to perform.
STAT
OCTOBER 15, 2024
On Sept. 26, the FDA approved the first truly new antipsychotic in decades: Cobenfy. In clinical trials, it didn’t cause certain side effects that traditionally interfere with medication adherence, including weight gain, lethargy, and movement disorders. I have schizoaffective disorder, bipolar type — a combination of schizophrenia and bipolar disorder — and I agree that this is a monumental development for my community.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmExec
OCTOBER 15, 2024
In this part of her video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One and Pharmaceutical Executive Advisory Board Member discusses how pharmaceutical companies can effectively balance personalized marketing efforts with maintaining data privacy and ensuring patient trust.
STAT
OCTOBER 15, 2024
It was a dramatic call to action by the American Heart Association: The organization declared its decade-long goal culminating in 2020 was to slash deaths from cardiovascular disease and stroke by 20%. It also promised in its scientific journal to move all Americans toward “ideal cardiovascular health.” That never happened. Deaths did decrease by 15% from 2010, but it was a “disappointment” that fatalities linked to conditions like high blood pressure, heart failure,
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Outsourcing Pharma
OCTOBER 15, 2024
As active pharmaceutical ingredients (APIs) and medicines become more complex and the demand for efficiency rises, drug developers and manufacturers must adapt their strategies to keep pace with the evolving landscape.
STAT
OCTOBER 15, 2024
Why aren’t we doing better in the battle against cardiovascular disease? Over the last few months, STAT put that question to nearly a dozen experts in cardiology, primary care, endocrinology, and vascular disease. Nearly all of them, as a related article details, pointed to a crisis in primary care.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
STAT
OCTOBER 15, 2024
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. With all eyes currently on the upcoming U.S. elections, it’s easy to forget that this year more than 75 countries have headed to the polls or will soon.
Pharmaceutical Technology
OCTOBER 15, 2024
Pharmaceutical giants cannot work in a silo to reach net zero. Pharma contract manufactures have a duty to engage with the science-based climate targets, says ACG.
PharmExec
OCTOBER 15, 2024
Expanded indication of Bimzelx offers a prefilled syringe with a single 2 mL subcutaneous injection, improving upon the previous regimen of two 1 mL injections.
pharmaphorum
OCTOBER 15, 2024
Health plans, employers, and healthcare providers plan to increase their spending on digital health technologies in the next 12 months, says PHTI survey
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Technology
OCTOBER 15, 2024
Discover the leading Parenteral Solutions in Pharmaceutical Contract Manufacturing. Download the free Buyer's Guide for full contact details.
pharmaphorum
OCTOBER 15, 2024
Transgene's therapeutic vaccine for cervical and anogenital cancers failed a phase 2 trial, but an efficacy signal warrants further study
PharmExec
OCTOBER 15, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
pharmaphorum
OCTOBER 15, 2024
Germany is the first market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
PharmExec
OCTOBER 15, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
OCTOBER 15, 2024
Lundbeck is to acquire Longboard for $2.6bn equity value in a move set to enhance its capabilities within neuro-rare conditions.
PharmExec
OCTOBER 15, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
pharmaphorum
OCTOBER 15, 2024
mRNA vaccines, pivotal in the fight against COVID-19, are now emerging as a promising innovation in cancer treatment.
Pharmacy Times
OCTOBER 15, 2024
The FDA faces a multitude of challenges in regulating artificial intelligence (AI) and machine learning (ML) medical devices.
Pharmaceutical Technology
OCTOBER 15, 2024
Boehringer Ingelheim, in partnership with the WHO Foundation, has committed $5m to enhance healthcare access.
Pharmaceutical Commerce
OCTOBER 15, 2024
The conference’s opening keynote sets the scene for 2025 and the years to come.
Pharma Times
OCTOBER 15, 2024
Partnership to harness AI for DUB-focused preclinical programmes
Pharmaceutical Commerce
OCTOBER 15, 2024
The latest news for pharma industry insiders.
The Guardian - Pharmaceutical Industry
OCTOBER 15, 2024
We call on leaders meeting at the World Health Summit to help remove all gender-related barriers to immunisation against diseases such as polio Dr Sania Nishtar is the chief executive officer of Gavi, the Vaccine Alliance and Svenja Schulze is Germany’s federal minister for economic cooperation and development When confronting diseases such as polio in Gaza and mpox outbreaks in some African countries, we must remember one of the biggest lessons ever learned in global health: women are essential
Expert insights. Personalized for you.
59 
Let's personalize your content